Drug
NPH
NPH is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_2
1
20%
Ph phase_3
1
20%
Ph not_applicable
2
40%
Ph phase_4
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A2 (40.0%)
Trials by Status
terminated120%
withdrawn120%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
terminatednot_applicable
Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
NCT00564018
completedphase_4
Inpatient Diabetes on Corticosteroids
NCT01970241
completedphase_2
Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
NCT01662921
withdrawnnot_applicable
The Inova Type 2 Diabetes Mellitus Study
NCT02222623
completedphase_3
Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis
NCT01461616
Clinical Trials (5)
Showing 5 of 5 trials
NCT00564018Not Applicable
Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
NCT01970241Phase 4
Inpatient Diabetes on Corticosteroids
NCT01662921Phase 2
Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
NCT02222623Not Applicable
The Inova Type 2 Diabetes Mellitus Study
NCT01461616Phase 3
Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5